======= KIAA0922 ======= == Gene Information == * **Official Symbol**: TMEM131L * **Official Name**: transmembrane 131 like * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23240|23240]] * **UniProt**: [[https://www.uniprot.org/uniprot/A2VDJ0|A2VDJ0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KIAA0922&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KIAA0922|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616243|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Isoform 1: Membrane-associated form that antagonizes canonical Wnt signaling by triggering lysosome-dependent degradation of Wnt-activated LRP6. Regulates thymocyte proliferation. {ECO:0000269|PubMed:23690469}. |DUF3651| |negative regulation of immature T cell proliferation in thymus| |negative regulation of immature T cell proliferation| |regulation of immature T cell proliferation in thymus| |negative regulation of T cell differentiation in thymus| |regulation of immature T cell proliferation| |regulation of T cell differentiation in thymus| |negative regulation of T cell differentiation| |negative regulation of lymphocyte differentiation| |negative regulation of T cell proliferation| |negative regulation of mononuclear cell proliferation| |negative regulation of lymphocyte proliferation| |negative regulation of leukocyte proliferation| |negative regulation of leukocyte differentiation| |negative regulation of T cell activation| |negative regulation of leukocyte cell-cell adhesion| |negative regulation of hemopoiesis| |regulation of T cell differentiation| |negative regulation of lymphocyte activation| |regulation of T cell proliferation| |regulation of lymphocyte differentiation| |negative regulation of cell-cell adhesion| |negative regulation of leukocyte activation| |negative regulation of canonical Wnt signaling pathway| |negative regulation of cell activation| |regulation of lymphocyte proliferation| |negative regulation of Wnt signaling pathway| |regulation of mononuclear cell proliferation| |regulation of leukocyte proliferation| |regulation of leukocyte differentiation| |negative regulation of cell adhesion| |regulation of canonical Wnt signaling pathway| |regulation of leukocyte cell-cell adhesion| |regulation of T cell activation| |Wnt signaling pathway| |cell-cell signaling by wnt| |regulation of Wnt signaling pathway| |regulation of cell-cell adhesion| |cell surface receptor signaling pathway involved in cell-cell signaling| |negative regulation of immune system process| |regulation of hemopoiesis| |regulation of lymphocyte activation| |regulation of leukocyte activation| |regulation of cell activation| |negative regulation of cell population proliferation| |regulation of cell adhesion| |negative regulation of cell differentiation| |negative regulation of developmental process| |endoplasmic reticulum| |cell-cell signaling| |negative regulation of multicellular organismal process| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |regulation of cell population proliferation| |negative regulation of response to stimulus| |regulation of immune system process| |regulation of cell differentiation| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-4.45| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|-2.97| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|-2.92| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-2.67| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-2.52| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|-2.11| |[[:results:exp429|Rapamycin 0.001μM R08 exp429]]|-1.91| |[[:results:exp512|Olaparib 4μM R08 exp512]]|-1.87| |[[:results:exp79|Q15 2.7μM R02 exp79]]|-1.82| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|1.76| |[[:results:exp274|Citral 50μM R06 exp274]]|1.79| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|2.12| |[[:results:exp492|iCRT14 30μM R08 exp492]]|2.89| ^Gene^Correlation^ |[[:human genes:t:tmem39a|TMEM39A]]|0.621| |[[:human genes:p:p4hb|P4HB]]|0.527| |[[:human genes:u:ufm1|UFM1]]|0.431| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17654 * **Expression level (log2 read counts)**: 8.29 {{:chemogenomics:nalm6 dist.png?nolink |}}